The impact of funding cuts on medical research is profound and far-reaching, threatening the integrity and safety of ongoing clinical trials.Recently, the Trump administration's decision to freeze over $2 billion in federal research grants to institutions like Harvard has disrupted vital oversight systems, including the SMART IRB initiative.